Yanayin Masana'antar Endoscopy ta Cikin Gida ta China

Darajar Kasuwa Yuan biliyan 2.3: Jerin Kamfanonin Masana'antar Endoscopy na Cikin Gida a Kasuwar Hannun Jari ta Beijing!

Sanannen abu ne cewa a cikin 'yan shekarun nan, tsufar al'umma a duniya, karuwar amfani da tiyata marasa amfani, da kuma hanzarta kirkire-kirkire na fasaha sun haifar da ci gaba da fadada kasuwar endoscopy ta likitanci. Kasuwar kasar Sin, wacce aka karfafa ta da goyon bayan manufofi, hanzarta maye gurbin gida, da kuma sakin bukatar kiwon lafiya ta farko, ta nuna ci gaban da ya zarce matsakaicin duniya.

A bisa kididdigar masana'antu, kasuwar kayan aikin duba lafiyar jiki ta duniya ta kai dala biliyan 32.98 a shekarar 2025. Ana hasashen cewa za ta karu zuwa dala biliyan 35.2 a shekarar 2026 kuma ta zarce dala biliyan 62 nan da shekarar 2035, tare da karuwar karuwar shekara-shekara (CAGR) da kusan kashi 6.5% daga shekarar 2026 zuwa 2035. Ci gaban ya samo asali ne daga shaharar da ake samu ta hanyar tiyata marasa cin zarafi, karuwar bukatar gwajin cututtuka da wuri, da kuma karuwar kayayyakin da ci gaban fasaha ke haifarwa.

A ranar 27 ga Maris,An yi Alkawari, wanda ke taka rawa a kasuwar endoscopy, an sanya shi a hukumance a Kasuwar Hannun Jari ta Beijing, inda ya cimma darajar kasuwa ta yuan biliyan 2.3. A cikin shekaru uku da suka gabata, kamfanin ya ci gaba da samun riba mai dorewa, tare da jimillar ribar da ta wuce yuan miliyan 150!

Bugu da ƙari, kamfanin yana shirin tara kusan Yuan miliyan 400 ta wannan jerin, musamman don ayyukan da suka shafi aikin huda ramuka, ayyukan da ba su da tasiri sosai, da sauran sassan kayan aikin likita.

Naúrar: RMB dubu goma

Kamfanin ya jaddada muhimmancin na'urorin likitanci masu ƙarancin shiga tsakani, musamman kayayyakin shiga tsakani masu ƙarancin shiga tsakani da ake amfani da su sau ɗaya. Wannan masana'antar a halin yanzu tana cikin wani mataki na ci gaba cikin sauri, tare da buƙatu da yawa na asibiti da ba a cika su ba da kuma manyan damammaki don haɓaka samfuran da ake da su akai-akai.

Bayanai sun nuna cewa kasuwar tiyata mai ƙarancin shiga jiki ta duniya (gami da na'urorin duban dan tayi masu ƙarfi, kayan aikin MIS, da MISIA) ta kai kimanin dala biliyan 29.87 a shekarar 2023. Ana sa ran wannan adadi zai haura zuwa dala biliyan 34.84 nan da shekarar 2025, tare da CAGR na kashi 8%, wanda hakan ya sa ta zama ɗaya daga cikin sassan ci gaba mafi ƙarfi a kasuwar na'urorin likitanci ta duniya.

An yi Alkawari An Jera a Hukumance: Girman Kasuwar Endoscopy Ya Ci Gaba Da Hauhawa!

Bisa lafazinAn yi Alkawari, fasahar endoscopic galibi an raba ta zuwa endoscopy da laparoscopy/thoracoscopy. Ganewar endoscopic da magani ya ƙunshi amfani da endoscope don bincika da magance cututtuka. Ta hanyar saka endoscope ta cikin jijiyoyin jiki na halitta, likitoci za su iya lura da canje-canje a cikin hanyoyin narkewar abinci ko na numfashi, gami da gyambo, ciwace-ciwacen daji, polyps, da kumburi. Ta hanyar dabarun kamar endoscopy na rami, ana iya yin maganin da ba shi da tasiri sosai a kan kyallen da ke wajen ramukan halitta.

Ana amfani da kayan aikin bincike da magani iri-iri waɗanda ba su da tasiri sosai tare da na'urorin endoscopes, waɗanda ke ƙara wa juna ƙarfi. Ana amfani da su sosai wajen gano cututtukan narkewar abinci kamar su ulcer na peptic, zubar jini a cikin hanji, cututtukan biliary tract, cututtukan hanta, da cututtukan pancreas. Bugu da ƙari, sassan kamar pulmonology, otorhinolaryngology, da urology suma suna amfani da waɗannan dabarun. Laparoscopy/thoracoscopy galibi yana shiga cikin ramukan jiki ta hanyar tiyata a cikin muhalli marasa tsabta, wanda ya ƙunshi dabarun kamar laparoscopy, thoracoscopy, da arthroscopy.

Kamfanin ya jaddada cewa a fannin gano cutar endoscopic da magani, kayayyakin endoscope na gargajiya galibi ana iya sake amfani da su. Waɗannan samfuran galibi suna da tsada kuma suna ɗauke da haɗarin kamuwa da cuta saboda rashin isasshen maganin kashe ƙwayoyin cuta.An yi AlkawariManufar kayayyakin maganin endoscopic ita ce a yi amfani da su sau ɗaya a rana, waɗanda za su iya magance matsalolin da aka ambata a sama da suka shafi kayayyakin da za a iya sake amfani da su. Wannan ɓangaren yana cikin wani ƙaramin masana'antar na'urorin likitanci mai tasowa tare da hasashen ci gaba a nan gaba.

A cewar hasashen Boston Scientific, girman kasuwar duniya ta na'urorin kwantar da hankali na endoscopic ya kai dala biliyan 6.0 a shekarar 2023, tare da tsammanin matsakaicin karuwar shekara-shekara na kashi 7% daga 2024 zuwa 2026.

A cikin 'yan shekarun nan, kasar Sin ta fuskanci karuwar tsufa a yawan jama'a, inda tsofaffi ke bukatar karin bincike da magani daga asibiti. A halin yanzu, yayin da yanayin rayuwa ke inganta, wayar da kan jama'a game da tantance cututtuka ya karu, wanda hakan ya kara bukatar yin gwaje-gwajen rigakafi. Bugu da kari, ci gaba da gyare-gyaren tsarin kiwon lafiya a kasar Sin na ci gaba da inganta tsarin kiwon lafiya da lafiya, wanda hakan ke baiwa cibiyoyin kiwon lafiya na farko damar samun kayan aikin endoscopic.

Saboda haka, sauye-sauyen alƙaluma na dogon lokaci, ƙaruwar yawan kamuwa da ciwon daji masu illa, shaharar gano cutar da magani mai ƙarancin mamaye jiki, ƙaruwar amfani da endoscopy da ƙimar magani (shiga ciki), da kuma ƙaruwar yawan maye gurbin gida duk suna haifar da ci gaba a kasuwar na'urorin bincike da warkarwa ta endoscopic ta China.

A cewar majiyoyi kamar CNKI, an kiyasta darajar kasuwar endoscope ta likitanci ta cikin gida ta kai Yuan biliyan 22.24 a shekarar 2022, inda kayayyakin da ake amfani da su a endoscopic suka kai Yuan biliyan 5. Ana hasashen cewa nan da shekarar 2030 (idan ba a yi la'akari da tasirin sayen kayayyaki a tsakiya ba), kasuwar endoscope ta likitanci ta cikin gida za ta kai Yuan biliyan 48.74, inda kayayyakin da ake amfani da su a endoscopic suka kai Yuan biliyan 14.92.

Daga cikin samfuran maganin endoscopic, ana sa ran na'urorin da ake amfani da su sau ɗaya, waɗanda ke kawar da buƙatar maganin kashe ƙwayoyin cuta da kuma guje wa haɗarin kamuwa da cuta, za su zama wani muhimmin ɓangare na kasuwar maganin endoscopic tare da kyakkyawan damar ci gaba.

Gane girman kasuwa da kuma darajar asibiti na samfuran endoscope masu amfani da su sau ɗaya,An yi Alkawari Nan da nan ya shiga fagen na'urorin likitanci na endoscopic da kayan amfani da ake amfani da su sau ɗaya. Kamfanin ya zuba jari sosai wajen haɓaka kayayyaki kamar na'urorin sarrafa hotunan endoscope na lantarki, na'urorin hangen nesa na bronchial visual catheters, na'urorin cholangioscope na lantarki da ake amfani da su sau ɗaya, da kuma na'urorin da ake amfani da su sau ɗaya a cikin rami.

An ƙaddamar da forceps na biopsy na kamfanin da ake amfani da shi sau ɗaya, wanda aka tsara don samun samfuran nama masu kama da juna cikin sauri a ƙarƙashin endoscopy tare da rage zubar jini da lalacewar endoscope, a ƙarshen 2023. An ƙaddamar da allurar endoscopic mai amfani sau ɗaya, wacce ke da ƙirar bututun ciki na musamman da kuma ƙarshen allura mai yankewa don tabbatar da ingantaccen ƙarfin hudawa da saurin kwarara, tare da makullin aminci don hana haɓakar allurar da ba ta dace ba wacce za ta iya lalata endoscope, a cikin 2024.

Bugu da ƙari, an ƙaddamar da wani tarko na lantarki mai amfani da shi sau ɗaya, wanda ke da ƙirar madauki mai lanƙwasa don haɓaka coagulation da juyawar digiri 360 don cire polyp, a cikin 2024. Tsarin kamfanin na samfuran maganin endoscopic yana da faɗi kuma ya ƙunshi fannoni daban-daban, yana da nufin samar da cibiyoyin kiwon lafiya na ƙasa da ƙasa da cikakkun hanyoyin magance samfuran endoscopic da ake amfani da su sau ɗaya, a ƙarshe yana ba wa marasa lafiya da ƙwararrun kiwon lafiya mafi kyau.

Daga mahangar samfuran endoscope, fasahar endoscope ta likitanci ta duniya tana ci gaba da bunƙasa cikin sauri zuwa ga ma'ana mafi girma, hankali, aikace-aikacen da ba su da amfani sosai, da kuma tsarin amfani da su sau ɗaya, wanda ke haifar da ci gaba da haɓaka aikin samfuri da faɗaɗa iyakokin aikace-aikacen asibiti.

Fasahar daukar hoto mai inganci tana ƙara zama ruwan dare a ko'ina. Na'urorin daukar hoto masu inganci na 4K sun zama babban zaɓin siyan kayan asibiti a duk faɗin duniya, suna ba da ƙuduri sama da layuka 2000 da kuma daidaiton launi 100% idan aka kwatanta da samfuran gargajiya. Wannan yana ba da damar ganin tsarin raunuka masu ƙananan ƙwayoyin cuta a sarari, yana ƙara yawan gano raunukan farko da kashi 25%. Na'urorin daukar hoto masu ƙuduri na 8K suna ƙara shiga kasuwa mai girma, galibi ana amfani da su a cikin yanayin tiyata mai inganci kamar tiyatar jijiyoyi da tiyatar thoracic.

Bugu da ƙari, haɗakar fasahar AI da endoscopes yana ƙara zurfafawa, yana zama babban alkibla ga ƙirƙirar masana'antu. A shekarar 2026, yawan shigarwa na kayan aikin ganewar asali na AI da aka taimaka wa a cikin endoscopes na likitanci ya kai 47%. Ta amfani da algorithms na zurfafa ilmantarwa, waɗannan kayan aikin suna ba da damar yin bayanin raunuka ta atomatik da kuma gano ma'auni, suna cimma daidaiton ganewar asali har zuwa 96.7%. Wannan yana wakiltar ƙaruwar inganci da kashi 40% idan aka kwatanta da ganewar asali da hannu, yayin da ake iya rage farashin likita da kashi 12%-15% da kuma rage zaman asibiti na marasa lafiya da kwanaki 1.8, wanda ke nuna muhimmancin ci gaba a cibiyoyin kiwon lafiya na farko.

Ci gaban Kasuwar Na'urorin Lafiya ta Duniya Mai Sauri: Ci gaban Kasuwar Cikin Gida Ya Fi Kasashen Waje Da Dama!

Daga mahangar kasuwar na'urorin likitanci, bukatar duniya na karuwa a 'yan shekarun nan saboda karuwar tsufar al'umma. A cewar Statista, an kiyasta kasuwar na'urorin likitanci ta duniya a kan dala biliyan 566.2 a shekarar 2023 kuma ana hasashen za ta kai dala biliyan 772.5 nan da shekarar 2029, tare da karuwar CAGR na 5.3%.

Saboda tallafin manufofi da kuma buƙatar likita, kasuwar na'urorin likitanci ta China ta ci gaba da samun ci gaba mai ɗorewa. A cewar "Littafin Shuɗi na Masana'antar Na'urorin Lafiya ta China (2024)," girman kasuwar masana'antar na'urorin likitanci ta China ya kai yuan tiriliyan 1.0328 a shekarar 2023, tare da CAGR na shekaru biyar na kimanin 13.43%. Kiyasin farko ya nuna cewa girman kasuwa zai kai yuan tiriliyan 1.1103 a shekarar 2024.

Ya kamata a lura cewa kayayyakin likitanci masu ƙarancin daraja suna nufin kayan likitanci da ake amfani da su sau ɗaya a lokacin ayyukan likita waɗanda ke da ƙarancin daraja. Dangane da takamaiman aikace-aikace, ana iya rarraba su zuwa kayan tsafta da miya na likita, kayan jiko da huda, kayan polymer na likitanci, kayayyakin kashe ƙwayoyin cuta na likita, kayan sa barci, kayan aikin tiyata, kayan aikin tiyata, kayan aikin tiyata, da kayan amfani na fasahar likitanci. Manyan kayayyakin kamfanin suna ƙarƙashin rukunin jiko da huda a cikin masana'antar kayan aikin likita masu ƙarancin daraja.

A matsayin kayan da ake amfani da su sau ɗaya, kayayyakin likitanci masu ƙarancin daraja suna ƙara aminci ga gwaje-gwaje da jiyya da kuma hana yaɗuwar cututtuka tsakanin masu samar da kiwon lafiya da marasa lafiya da na'urorin likitanci na gama gari ke haifarwa. Tare da ƙaruwar buƙatun tsaftar lafiya, mahimmancin su a ayyukan kiwon lafiya yana ƙaruwa koyaushe.

A cewar kididdigar "China Medical Device Blue Book (2024)" da Cibiyar Bincike ta Masana'antar Kasuwanci ta China, kasuwar kayayyakin kiwon lafiya masu ƙarancin daraja a duniya tana da girma kuma tana nuna ci gaba mai ɗorewa, wanda ya kai dala biliyan 72.2 a shekarar 2023.

Sakamakon gyare-gyare a tsarin amfani da magunguna da na'urorin likitanci na kasar Sin, inganta yanayin lafiya, karuwar inshorar lafiya, da kuma karin karfin biyan kudin zama a kasar, masana'antar kayayyakin kiwon lafiya masu rahusa a cikin gida na ci gaba da bunkasa a hankali, wanda ke gabatar da faffadan damarmaki a kasuwa.

A cewar kiyasin "Littafin Shudi na Masana'antar Kayan Aikin Likitanci ta China (2024)" da Cibiyar Bincike ta Masana'antar Kasuwanci ta China, kasuwar kayayyakin kiwon lafiya masu ƙarancin daraja ta cikin gida ta kai yuan biliyan 128 a shekarar 2023.

Bugu da ƙari, na'urorin jiko da huda suna wakiltar wani muhimmin rukuni a cikin kayan amfani na likitanci masu ƙarancin daraja. Waɗannan na'urori galibi suna amfani da allurar huda ko allurar allura don shiga jiki don dalilai kamar su ƙarin jini, jiko na ruwa, maganin sa barci, angiography, ɗaukar jini don gwaje-gwaje, da sauransu. A cewar Cibiyar Bincike ta Masana'antar Kasuwanci ta China, girman kasuwar China don jiko na likita da huda ya kai yuan biliyan 33.16 a shekarar 2022 kuma ana hasashen zai kai yuan biliyan 52.31 nan da shekarar 2026.

Daga mahangar kasuwar endoscope, masana'antar endoscopy ta likitanci ta duniya tana cikin wani yanayi na ci gaba mai kyau. Sabbin fasahohi, shaharar da ake samu wajen tiyatar da ba ta da tasiri sosai, da kuma tsufar jama'a su ne manyan abubuwan da ke haifar da ci gaban masana'antu. Kasuwar yankin tana nuna wani tsari da aka siffanta da "shugabannin Asiya-Pacific, Turai da Arewacin Amurka sun girma." Manyan kamfanoni na duniya sun mamaye kasuwar, yayin da kamfanoni masu tasowa ke ci gaba da hauhawa a hankali.

Ganin yadda ake cin gajiyar abubuwa da dama masu kyau kamar tallafin manufofi, hanzarta maye gurbinsu a cikin gida, da kuma sakin buƙata daga fannin kiwon lafiya na farko, kasuwar endoscopy ta likitanci ta kasar Sin tana nuna ci gaba mai sauri, inda yawan karuwar kasuwa ke kan gaba a duniya. Gasar da kamfanonin cikin gida ke ci gaba da bunkasa, tana karya ikon mallakar shigo da kayayyaki daga kasashen waje a hankali.

Duk da cewa masana'antun endoscopy na likitanci na duniya da na China har yanzu suna fuskantar ƙalubale kamar matsalolin fasaha na asali, rashin isassun gasa a fannin kasuwanci, da kuma rashin daidaiton rarraba albarkatun likitanci, makomar ci gaban masana'antar a nan gaba tana da faɗi, wanda ci gaba da sabbin fasahohi, ƙarfafa tallafin manufofi, da kuma ci gaba da buƙatar kasuwa ke haifarwa.

Kasuwar duniya za ta ci gaba da ci gaba zuwa ga manyan manufofi, masu hankali, da kuma amfani da su sau ɗaya. Kasancewar maye gurbin gida, faɗaɗawa zuwa fannin kiwon lafiya na farko, da kuma faɗaɗa duniya, kasuwar Sin tana shirye ta cimma ci gaba mai inganci, a hankali tana sauyawa daga "babban ƙasa mai samar da endoscope" zuwa "ƙarfin kirkire-kirkire," wanda ke ba da gudummawa ga ƙarfin Sin ga ci gaban masana'antar endoscopy na likitanci na duniya.

Ganin yadda China ke samun ci gaba cikin sauri'Kasuwar endoscopy ta s, mu a ZRHmed—a matsayin mai samar da kayan haɗin endoscopic—Muna alfahari da kasancewa cikin wannan ci gaba kuma muna da niyyar haɓaka kasuwa tare, har ma tare da mai fafatawa da mu, Pioneer.

Mu, Jiangxi Zhuoruihua Medical Instrument Co., Ltd., kamfani ne da ke kera kayayyaki a China, wanda ya ƙware a fannin amfani da endoscopic, gami da Endotherapy Series kamar suƙarfin biops,hemoclip, tarkon polyp, allurar sclerotherapy, feshi catheter, gogewar cytology, waya mai jagora, Kwandon ɗaukar dutse, cathete na magudanar biliary na hancida sauransu. wanda ake amfani da shi sosai a cikin EMR, ESD, ERCP.

Kayayyakinmu an ba su takardar shaidar CE kuma an ba su takardar shaidar FDA 510K, kuma masana'antunmu an ba su takardar shaidar ISO. An fitar da kayayyakinmu zuwa Turai, Arewacin Amurka, Gabas ta Tsakiya da wani ɓangare na Asiya, kuma suna ba wa abokin ciniki yabo sosai!